Iguratimod
- ₹3500 - ₹42877.83
- Product name: Iguratimod
- CAS: 123663-49-0
- MF: C17H14N2O6S
- MW: 374.37
- EINECS:808-127-0
- MDL Number:MFCD00882374
- Synonyms:iguratimod( R&D);T 614;N-[7-methanesulfonamido-4-oxo-6-(phenoxy)chromen-3-yl]formamide;3-(Formylamino)-7-(methylsulfonylamino)-6-phenoxy-4H-1-benzopyran-4-one;N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide;IguratiMod (T 614);IGURATIMOD;CS-1961
4 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
- TCI Chemicals (India)
Package
- 5MG
- 25MG
- 250MG
- ManufacturerSigma-Aldrich(India)
- Product numberSML1898
- Product descriptionIguratimod ≥98% (HPLC)
- Packaging5MG
- Price₹10619.33
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberSML1898
- Product descriptionIguratimod ≥98% (HPLC)
- Packaging25MG
- Price₹42877.83
- Updated2022-06-14
- Buy
- ManufacturerTCI Chemicals (India)
- Product numberI0945
- Product descriptionIguratimod
- Packaging250MG
- Price₹14800
- Updated2022-05-26
- Buy
- ManufacturerTCI Chemicals (India)
- Product numberI0945
- Product descriptionIguratimod
- Packaging25MG
- Price₹3500
- Updated2022-05-26
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | SML1898 | Iguratimod ≥98% (HPLC) | 5MG | ₹10619.33 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SML1898 | Iguratimod ≥98% (HPLC) | 25MG | ₹42877.83 | 2022-06-14 | Buy |
TCI Chemicals (India) | I0945 | Iguratimod | 250MG | ₹14800 | 2022-05-26 | Buy |
TCI Chemicals (India) | I0945 | Iguratimod | 25MG | ₹3500 | 2022-05-26 | Buy |
Properties
Melting point :238.0 to 242.0 °C
Boiling point :580.6±60.0 °C(Predicted)
Density :1.52±0.1 g/cm3(Predicted)
storage temp. :under inert gas (nitrogen or Argon) at 2-8°C
solubility :DMSO (Slightly)
form :Solid
pka :5.58±0.20(Predicted)
color :White to Off-White
Boiling point :580.6±60.0 °C(Predicted)
Density :1.52±0.1 g/cm3(Predicted)
storage temp. :under inert gas (nitrogen or Argon) at 2-8°C
solubility :DMSO (Slightly)
form :Solid
pka :5.58±0.20(Predicted)
color :White to Off-White
Safety Information
Symbol(GHS): | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|
Description
In August 2011, China’s State FDA approved Simcere Pharmaceutical Group’s new drug application for iguratimod (T-614), a disease modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Preclinical in vivo studies indicated that iguratimod was effective in an established adjuvant-induced arthritis model (ED40=3.6 mg/kg) in rats and also efficacious in a type II collagen-induced arthritis model in DBA/1J mice at 30 mg and 100 mg/kg.
Related product price
- Formamide
₹738-121960 - DIETHOXYMETHANE
₹1602-8700 - Dimethoxymethane
₹972-15891.1